Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Sep 14.
Published in final edited form as: Nat Commun. 2015 Aug 13;6:8010. doi: 10.1038/ncomms9010

Intestinal macrophages arising from CCR2+ monocytes control pathogen infection by activating innate lymphoid cells

Sang-Uk Seo 2, Peter Kuffa 1, Sho Kitamoto 1, Hiroko Nagao-Kitamoto 1, Jenna Rousseau 1, Yun-Gi Kim 2, Gabriel Núñez 2, Nobuhiko Kamada 1
PMCID: PMC4536571  NIHMSID: NIHMS706358  PMID: 26269452

Abstract

Monocytes play a crucial role in antimicrobial host defense, but the mechanisms by which they protect the host during intestinal infection remains poorly understood. Here we show that depletion of CCR2+ monocytes results in impaired clearance of the intestinal pathogen Citrobacter rodentium. After infection, the de novo recruited CCR2+ monocytes give rise to CD11c+CD11b+F4/80+CD103 intestinal macrophages (MP) within the lamina propria. Unlike resident intestinal MPs, de novo differentiated MPs are phenotypically pro-inflammatory and produce robust amounts of IL-1β through the non-canonical caspase-11 inflammasome. Intestinal MPs from infected mice elicit the activation of RORγt+ group 3 innate lymphoid cells (ILC3) in an IL-1β-dependent manner. Deletion of IL-1β in blood monocytes blunts the production of IL-22 by ILC3 and increases the susceptibility to infection. Collectively, these studies highlight a critical role of de novo differentiated monocyte-derived intestinal MPs in ILC3-mediated host defense against intestinal infection.

Introduction

Intestinal resident mononuclear phagocytes, including macrophages (MPs) or dendritic cells (DCs), are innate immune cells that play a central role in gastrointestinal homeostasis 1. Intestinal MPs are defined as cells that express MHC class II, CD11b, the pan-MP marker F4/80, and a receptor for fractalkine CX3CR1 while lacking αE integrin CD103 2, 3. Intestinal MPs display immune-regulatory properties that are critical for host tolerance to innocuous antigens, such as dietary antigens as well as commensal microorganisms. For example, IL-10 robustly produced by intestinal MPs contributes to dampening of mucosal inflammation as well as the differentiation and maintenance of regulatory T cells in the intestine 2, 3, 4. Although most tissue resident MPs are believed to arise from progenitors during embryonic development and are generated by self-renewal in resident tissues, the maintenance of intestinal MPs requires constant de novo migration of Ly6Chi CCR2+ blood monocytes to intestinal tissues for replenishment 1, 3, 5, 6. In the presence of enteric infection, blood Ly6Chi CCR2+ monocytes are recruited to the sites of infection where they promote inflammatory responses that facilitate pathogen clearance 7, 8, 9. How recruited monocytes phenotypically switch from “immune-regulatory” to “immune-stimulatory” in the intestine following infection, and the significance of such a timely phenotypic change, however, remain poorly understood.

Recent evidence suggests that a subset of innate-type lymphocytes, known as innate lymphoid cells (ILCs), play a crucial role in protecting the host from intestinal infections 10, 11. These ILCs differ from B and T cells in that they lack antigen receptors. However, because ILCs share developmental and functional similarities with T cells, ILCs have been categorized into three major groups based on the on their cytokine profile and the transcription factors required for their development: T-bet+ group 1 ILCs (ILC1) akin to Th1 cells that produce IFNγ and TNFα, GATA-3+ group 2 ILCs (ILC2) are similar to Th2 cells and produce IL-5, IL-9 and IL-13, and RORγt+ group 3 ILCs (ILC3) that produce IL-17 and/or IL-22 12, 13, 14, 15. IL-22 produced by ILC3 plays a key role in ILC-mediated host defense against intestinal infection by enhancing intestinal epithelial barrier function 11, 16. Although the mechanisms leading to ILC activation during intestinal infection remain poorly understood, intestinal MPs and/or DCs are capable of inducing the production of IL-22 by ILC3 through IL-23 and IL-1β 17, 18, 19, 20. However, it remains largely unknown how these tissue resident MPs and/or DCs acquire the ability to activate ILCs, since resident intestinal MPs are hyporesponsive to microbial stimulation and poorly produce IL-23 and IL-1β 3, 4.

In this study, we provide evidence that CCR2+ monocytes are recruited to the intestinal lamina propria (LP) upon pathogen infection and rapidly give rise to a subset of intestinal MPs in situ that activate RORγt+ ILC3s through caspase-11 inflammasome-dependent IL-1β production. Our findings demonstrate how microbial signals from the pathogen shape the differentiation of newly recruited monocytes into “inflammatory” intestinal MPs that ultimately licenses them to clear the pathogen through activation of RORγt+ ILC3s. Thus, our study highlights a concerted effort by two critical innate immune cell types to orchestrate host defense against pathogen infection in the intestine.

Results

Monocyte recruitment is critical for ILCs activation

To assess the role of recruited monocytes in the control of intestinal infection, C. rodentium was orally administered to either wild-type (WT) mice and mice deficient in CCR2, an essential chemokine receptor for emigration of Ly6Chi monocytes from the bone-marrow (BM) and recruitment to the intestine 21. Compared to WT mice, the clearance of C. rodentium was markedly impaired in Ccr2−/− mice on day 14 and day 18 (Fig. 1a), in agreement with previous results 9. The production of IFN-γ, IL-17A, and IL-22 by colonic LP cells was reduced in Ccr2−/− mice on day 12 post-infection (Fig. 1b). Consistent with impaired IL-22 production, expression of RegIIIβ and RegIIIγ, two known downstream targets of IL-22 11, 16, in intestinal epithelial cells was significantly decreased in Ccr2−/− mice (supplementary Fig. 1). Together, these results suggested that the recruitment of monocytes to the intestine regulates the activation of lymphocyte responses in response to pathogen infection. To exclude the possibility that developmental defects contributed to the phenotype in Ccr2−/− mice, we used conditional CCR2-DTR-depleter mice in which CCR2+ monocytes and monocyte-derived CCR2+ cells are selectively deleted after diphtheria toxin (DT) administration 22. To assess the role of CCR2+ monocytes in C. rodentium infection, CCR2DTR/+ and WT littermates (CCR2WT) mice were infected with the pathogen followed by administration of DT. CCR2WT mice, where monocytes were unaffected after DT treatment, cleared the pathogen from the intestine, and none of animals succumbed to infection (Fig. 1c, d). In contrast, CCR2DTR mice where monocytes were depleted displayed impaired eradication of C. rodentium on days 14 and 16, and ~ 60% succumbed by day 21 post-infection (Fig. 1c, d). As observed in Ccr2−/− mice, mucosal IFN-γ, IL-17A, and IL-22 production was significantly reduced in CCR2DTR mice when compared to control CCR2WT littermates (Fig. 1e). IL-22 is produced by both T cells and ILCs and plays a critical role in protecting the host against C. rodentium 11, 16. To identify the cellular source of IL-22 during C. rodentium infection, Th17 cells (RORγt+CD3+CD4+) and ILC3s (RORγt+CD3) were sorted from the intestines of C. rodentium infected mice, and IL-22 expression in these lymphoid subsets was assessed by intracellular staining. ILC3 produced greater levels of IL-22 than Th17 cells (Fig. 1f). To determine the role of monocyte recruitment in the production of IL-22 by ILC3 cells during C. rodentium infection, CCR2WT and CCR2DTR mice were injected with DT after C. rodentium infection. Consistent with the results in Fig. 1f, mucosal ILCs (LinThy-1+CD3CD4 and LinThy-1+CD3CD4+) produced IL-22 on day 8 post-infection (Fig. 1g). Notably, the production of IL-22 was blunted in CCR2DTR mice compared to control CCR2WT littermates (Fig. 1g). Likewise, the absolute number of IL-22-producing ILCs was significantly decreased in CCR2DTR mice, while IL-22-producing T cells exhibited a trend, but not a significant reduction in CCR2DTR mice (Fig. 1h). To further assess the role of monocytes in the activation of ILCs, we generated CCR2DTR mice in a Rag1−/− background in which the main source of IL-22 are expected to be CD3 ILCs. Consistently, LP cells from Rag1−/−CCR2WT mice produced robust amounts of IL-22 after C. rodentium infection, suggesting that ILCs are the major source of mucosal IL-22 in response to pathogen infection (Fig. 1i). The production of IL-22, IFNγ and IL-17A were blunted in Rag1−/−CCR2DTR mice injected with DT compared to Rag1−/−CCR2WT mice, indicating that monocytes are also critical for production of these cytokines in the absence of T cells (Fig. 1i). To determine the role of monocytes for host defense in the absence of T cells, we infected Rag1−/−CCR2DTR and Rag1−/− mice and monitored mouse survival over time. The mortality of Rag1−/−CCR2DTR pretreated with DT was accelerated compared to Rag1−/−CCR2WT mice (Fig. 1j). Collectively, these results indicate that monocytes recruited to the intestine are critical for the activation of mucosal ILC3 and host defense during C. rodentium infection.

Figure 1. Recruitment of CCR2+ monocytes activate ILCs during intestinal infection.

Figure 1

(a) C. rodentium burden in feces from Ccr2+/+ and Ccr2−/− mice. Data represent mean ± s.d. (n=5, representative of 2 independent experiments). (b) Colonic lamina propria mononuclear cells (LPMCs) were isolated from at 0 and 12 days post infection (dpi), and cultured for 24 hrs. Produced cytokines were measured by ELISA. Data represent mean ± s.d. (n=5 from 2 individual experiments). N.D., not detected. (c, d) CCR2WT and CCR2DTR mice were infected with C. rodentium and diphtheria toxin (DT; 10 ng g−1 body weight) was injected on 5, 7, 9, 11 dpi. Bacterial burden (c) and mouse mortality (d) are shown. Dots represent individual mice. Results are representative of 2 independent experiments. (e) Cytokines produced by LPMC at 8 dpi. Data represent mean ± s.d. (n=3, representative of 3 independent experiments). (f) RORγtGFP/+ mice were infected with C. rodentium. LPMCs were isolated on 8 dpi and Th17 (CD3+CD4+RORγt+) and ILC3 (CD3RORγt+) were purified by sorting. IL-22 mRNA expression was assessed by qPCR. Data represent mean ± s.d. (n=3, representative of 2 independent experiments). (g, h) CCR2WT and CCR2DTR mice were infected with C. rodentium and DT was injected on days 5, 7. LPMCs were isolated on 8 dpi, and cultured in the presence of heat-killed C. rodentium (MOI=10) for 16 hrs. IL-22 production in CD4 ILCs (LinThy-1+CD3CD4), CD4+ ILCs (LinThy-1+CD3CD4+), and CD4+ T cells (Thy-1+CD3+CD4+) was assessed by flow cytometry (g), and absolute number of IL-22 producing T cells and ILCs are shown in (h). (i) Rag1−/−CCR2WT and Rag1−/−CCR2DTR mice were infected with C. rodentium and DT was injected on days 5, 7. LPMCs were isolated on 8 dpi and cultured for 24 hrs. Cytokines were measured by ELISA. Data represent mean ± s.d. (n=4, representative of 2 independent experiments). (j) Mouse mortality of Rag1−/−CCR2WT and Rag1−/−CCR2DTR mice (n=5) infected with C. rodentium. DT was injected on day 5, 7, 9, 11 post-infection. N.S., not significant, *p<0.05, **p<0.01, ***p<0.001 by Mann-Whitney U test (a, b, c), Student’s t test (e, h, i), and Log-rank test (d, j).

Recruited monocytes give rise to intestinal macrophages

CCR2+ monocytes in peripheral blood express Ly6C and CSF-1R (also known as the M-CSF receptor or CD115) 23, 24. Although certain subsets of LP mononuclear phagocytes arise from CCR2+Ly6Chi blood monocytes, these monocyte-derived LP mononuclear phagocytes do not express CCR2 in the intestine 23, 24. Consistent with previous reports 25, Ly6Chi monocytes in peripheral blood expressed both CCR2 and CD115 (Fig. 2a). In contrast, CD115+ cells in the intestinal LP did not express CCR2 (Fig. 2a), suggesting that CCR2 is down-regulated in the intestinal LP. We therefore used CD115 as a marker of monocytes and monocyte-derived mononuclear phagocytes in the intestine instead of CCR2 and used CD115-GFP reporter mice to analyze CCR2+ monocyte-derived mononuclear phagocytes subsets 26. To characterize CD115+ and CD115 mononuclear phagocyte subsets in the intestinal LP, total mononuclear cells were isolated from the intestinal LP and CD45+MHC-II+ mononuclear phagocytes were further classified into four subsets based on the expression of CD11b, CD11c, F4/80 and CD103 (Fig. 2b). Consistent with previous results, two subsets of monocyte-derived mononuclear phagocytes (CD11b+CD11c+F4/80+CD103, referred to as MP subset 1 (MP1) and CD11b+CD11cF4/80+CD103, referred to as MP subset 2 (MP2)) expressed the monocyte-derived cell marker CD115 (Fig. 2b). In contrast, the DC subsets, which are thought to arise exclusively from a common DC progenitor, DC1 (CD11bCD11c+F4/80CD103+) and DC2 (CD11b+CD11c+F4/80CD103+) lacked CD115 expression (Fig. 2b). Both MP and DC subsets in the colon lacked Gr-1 expression, suggesting that recruited monocytes down-regulate the expression of Gr-1 after they reach mucosal sites (Fig. 2b). The DC2 subset (CD11chiCD11b+CD103+F4/80) is relatively rare in the colon, while it is more abundant in the small intestine (supplementary Fig. 2). Based on the expression of the monocyte marker CD115, the MP1 and MP2 subsets appear to arise from recruited monocytes. To confirm this, we depleted CCR2+ monocytes from CD115-reporter/CCR2-depleter (CD115GFPCCR2DTR-CFP) mice using DT. As expected, monocyte-depletion led to a reduction of the MP1 subset (supplementary Fig. 3). We then confirmed this result in C. rodentium infected mice. Consistent with the results in uninfected mice, monocyte-depletion affected the CD115+CD11c+ MP1 subset but did not impact on the number of MP2 and DC1 cells, suggesting that recruited monocytes preferentially give rise to the MP1 subset during infection (Fig. 2c). To further verify this, CD115-GFP+ monocytes were purified from the BM and transferred into C. rodentium-infected Ccr2−/− recipient mice on day 4 post-infection (Fig. 2d). The transferred CD115-GFP+ monocyte-derived cells were found in the colonic LP on days 3 and 10 after monocyte transfer (days 7 and 14 post-infection), but not in the spleen or mesenteric lymph nodes (MLN) (Fig. 2e and supplementary Fig. 4). These results indicate that monocytes preferentially migrate to the colonic LP in infected mice. Notably, while isolated monocytes expressed CD11b and Gr-1 and lacked CD11c prior to the transfer, the CD115-GFP+ monocytes recovered from the colonic LP expressed CD11c but down-regulated Gr-1 expression (Fig. 2f), indicating that monocytes differentiate into the MP1 subset after migration to the colonic LP.

Figure 2. Recruited monocytes give rise to intestinal CD115hiCD11chi CCR2 macrophages during infection.

Figure 2

(a) Peripheral blood and colonic LP cells were isolated from CD115GFP and CD115GFPCCR2CFP mice. Analysis of CD45+CD11b+Ly6Chi monocytes in peripheral blood and CD45+MHC-II+CD115GFP cells in colonic LP. (b) CD45+MHC-II+ colonic mononuclear phagocytes from CD115GFP mice were further analyzed by flow cytometry. (c) CD115GFP and CD115GFPCCR2CFP-DTR mice were infected with C. rodentium and DT (10 ng g−1 body weight) was injected on days 5 and 7. LPMC were isolated on day 8 post-infection and CD45+MHC-II+Gr-1 colonic mononuclear phagocytes were analyzed. (d) Ccr2−/− mice were infected with C. rodentium. On day 4 post-infection, CD11b+Ly6Chi bone-marrow monocytes were isolated from CD115gfp mice and transferred into Ccr2−/− recipient mice. The presence of GFP+ cells in the colonic LP on day 7 and 14 post C. rodentium infection (day 3 and 10 post monocyte transfer) was assessed (e). (f) The surface marker profile of purified bone-marrow monocytes (pre-infection) and monocytes recovered from the colonic LP on day 7 post C. rodentium infection (day 3 post monocyte transfer). Results are representative of at least 2 independent experiments.

The MP1 subset is a major producer of IL-1β and IL-23

Since our data demonstrated that newly recruited monocytes give rise to the MP1 subset in situ during infection, we next assess how the MP1 subset regulates host defense during infection. We first compared the cytokine profile of the MP1 subset and the “non-monocyte derived” CD103+ DC1 subset which is known to play an important role in the induction of IL-22 in response to flagellin injection 17. The MP1 and DC1 subsets were purified from the intestines of C. rodentium infected and uninfected mice to assess their cytokine profiles. As shown in Fig. 3a, the MP1 subset from infected mice expressed higher mRNA levels of pro-inflammatory cytokines, including IL-1β, IL-23p19, and IL-6, than MP1 cells from uninfected mice or the DC1 subset from uninfected or infected mice. Although most cytokines were found to be expressed at higher levels in MP1 compared to DC1 cells, IL-12/23p40 mRNA levels were higher in the DC1 subset (Fig. 3a). Consistently, MP1 cells from infected intestines produced higher amounts of IL-1β and IL-23 than MP1 cells from naïve mice or the DC1 subset, while IL-12/23p40 production was much higher in the DC1 subset (Fig. 3b). To address whether the CCR2+ monocyte-derived MP1 subset is the major source of IL-1β and IL-23 during C. rodentium infection, CCR2WT and CCR2DTR/+ mice were infected with C. rodentium, and cytokine production by colonic LP cells was evaluated. The production of IL-1β and IL-23, but not IL-6, was almost abrogated in CCR2DTR/+ mice treated with DT (Fig. 3c), indicating that the CCR2+ monocyte-derived MP1 subset is the major producer of IL-1β and IL-23 during C. rodentium.

Figure 3. Monocyte-derived intestinal macrophages are major producers of IL-1β and IL-23.

Figure 3

(a) MP1 and DC1 subsets were isolated from uninfected (uninf) and C. rodentium-infected (inf) CD115gfp animals. Cytokine mRNA expression was analyzed by qPCR. Data are given as mean ± s.d. (n=5–7). *p<0.05; **p<0.01; ***p<0.001; N.S., not significant by Dunn’s test. (b) Purified MP1 and DC1 subsets (1 × 106 cells/ml) were cultured for 24 hrs without stimulation. Cytokines in the culture supernatant were analyzed by ELISA. Data are given as mean ± s.d. (n=4–6). (c) LPMCs were isolated from C. rodentium-infected CCR2WT and CCR2DTR mice. 2 × 106 cells ml−1 LPMCs were cultured for 24 hrs without stimulation. Cytokines in the culture supernatant were analyzed by ELISA. Data are given as mean ± s.d. (n=3, representative of 3 independent experiments). *** p<0.001; N.S., not significant by Student’s t test.

The MP1 subset activates ILC3 via IL-1β

Given that IL-1β and IL-23 are critical activators of ILCs 20, 27, we hypothesized that the monocyte-derived MP1 subset activates ILCs. We first tested the role of IL-1β and IL-23 in the activation of ILC3s isolated from the intestine. RORγt+CD3+CD4+ Th17 cells and RORγt+CD3 ILC3s were isolated from the intestinal LP. About half of the ILC3s expressed NKp46, a marker found specifically on ILC3 but not on Th17 cells (supplementary Fig. 5a). Purified Th17 cells and ILC3s were then stimulated with recombinant IL-1β, IL-23, and IL-1β plus IL-23. Consistent with previous reports 20, 27, both IL-23 and IL-1β induced IL-22 secretion by ILC3s (supplementary Fig. 5b). Moreover, these cytokines synergistically induced IL-22 production in ILC3s (supplementary Fig. 5b). Additionally, co-stimulation with IL-23 and IL-1β induced ILC3s to produce robust amounts of IFN-γ, while stimulation with IL-23 or IL-1β alone did not (supplementary Fig. 5b). In contrast, Th17 cells produced higher amounts of IL-17A than ILC3s but minimal amounts of IFN-γ and IL-22, even after dual stimulation with IL-23 and IL-1β (supplementary Fig. 5b). To address whether the monocyte-derived intestinal MP1 cells can activate ILCs through IL-23 and IL-1β, RORγt+CD3 ILC3 and the MP1 subset were purified from the intestine, and then co-cultured ex vivo. Individually cultured ILC3 and MP1 cells did not produce IL-22, even after stimulation with heat-killed C. rodentium (Fig. 4a). However, co-culture of ILC and MP1 induced IL-22 production, which was further enhanced in the presence of C. rodentium (Fig. 4a). While ILC3-MP1 co-culture did not promote IFN-γ or IL-17A production, stimulation with C. rodentium robustly induced IFN-γ production by ILC3s in the presence of MP1 cells (Fig. 4a). Notably, the production of both IL-22 and IFN-γ by ILC3s co-cultured with MP1 was diminished by neutralizing antibody against IL-1β, but not IL-23p19 (Fig. 4a). These results demonstrate that IL-1β produced by monocyte-derived MPs is a key inducer of IL-22 and IFN-γ production by ILC3.

Figure 4. Activation of RORγt+ ILCs requires IL-1β produced by monocyte-derived intestinal macrophages during Citrobacter rodentium infection.

Figure 4

(a) CD3RORγt+ ILCs from uninfected RORγtGFP/+ reporter mice and MP1 cells from C. rodentium-infected CD115gfp were isolated. ILCs and MP1 cells (1 × 106 cells ml−1) were cultured alone or co-cultured with or without stimulation with heat-killed C. rodentium (MOI=10) for 24 hrs. Neutralizing antibodies for IL-23 (10 μg ml−1), IL-1β (10 μg ml−1), or isotype controls were used to block cytokines. Data are given as mean ± SD (n=4). *p<0.05; N.S., not significant by Dunnett’s test (compared to isotype control). (b) Schematic illustrating experimental protocol of mixed bone-marrow chimera for IL-1β monocyte/macrophage-conditional depletion. Lethally irradiated C57BL/6 recipient mice were reconstituted with mixed bone-marrows from Ccr2WT or Ccr2DTR and Il1b−/− mice (1:1 ratio) for 8 weeks. After 8 weeks, mice were infected with C. rodentium, and CCR2+ monocytes and monocyte-derived MP1 cells were depleted by DT injection (10 ng g−1 body weight) on days 5, 7, 9, 11 post-infection. (c) Survival of chimeric mice infected with C. rodentium (n=7). ** p<0.01 by Log-rank test. Results are pooled data of 2 independent experiments with 3–4 mice each. (d) CCR2WT/Il1b−/− control chimera (IL-1βWT) and CCR2DTR/Il1b−/− chimera (IL-1βΔMo/MP) were infected with C. rodentium and DT was injected (10 ng g−1 body weight) on days 5, 7. LPMCs were isolated on day 8 post-infection. 2 × 106 cells ml−1 LPMCs were cultured with or without stimulation with heat-killed C. rodentium (MOI=10) for 24 hrs. Cytokines in the culture supernatant were analyzed by ELISA. Data are given as mean ± s.d. (n=4, representative of 2 independent experiments). * p<0.05; ** p<0.01; *** p<0.001 by Student’s t test. (e) Isolated LPMCs in (d) were cultured in the presence of heat-killed C. rodentium (MOI=10) for 16 hrs. IL-22 production in CD4 ILCs (LinThy-1+CD3CD4) and CD4+ ILCs (LinThy-1+CD3CD4+) was assessed by flow cytometry. Data are representative of 4 individual mice.

Next, we evaluated the importance of IL-1β produced by monocyte-derived intestinal MPs in IL-22-mediated host defense in vivo. To address this, we generated IL-1β CCR2+ monocyte/MP conditional depleter mice using mixed bone-marrow chimeras. In these experiments, CCR2WT or CCR2DTR/+ bone-marrow cells mixed with bone marrow cells from Il1b−/− mice at a 1:1 ratio were transplanted into lethally irradiated WT mice (Fig. 4b and supplementary Fig. 6a). When we infected mixed chimeric mice orally with C. rodentium, CCR2DTR/Il1b−/− chimeric mice (IL-1βΔMo/MP) were more susceptible to C. rodentium and succumbed faster to infection than CCR2WT/Il1b−/− chimeric mice (IL-1βWT) (Fig. 4c). Although the number of monocyte-derived intestinal MPs (MHC-II+CD11b+F4/80+) was identical in both groups after DT injection (supplementary Fig. 7), depletion of DTR-expressing monocytes affected IL-1β production by LP cells in IL-1βΔMo/MP mice, but not in IL-1βWT mice (Fig. 4d and supplementary Fig. 6b). Consistent with compromised IL-1β production in IL-1βΔMo/MP mice, IL-22 production by total LP cells was blunted, while IL-6 production was increased in IL-1βΔMo/MP mice (Fig. 4d). More importantly, IL-22 production by ILCs was blunted in IL-1βΔMo/MP mice as it was observed in monocyte-depleted mice (Fig. 4e). Notably, control chimeric animals (IL-1βWT) were susceptible to C. rodentium whereas non-chimeric WT mice were completely protected (Fig. 1d and 4c). The latter might be due to reduced levels of IL-1β in control chimeric animals (IL-1βWT) since about half of BM cells in control chimeric animals derives from Il1b−/− mice (supplementary Fig. 6b). Thus, IL-1β produced by monocyte-derived intestinal MPs plays a crucial role in host protection against C. rodentium by promoting the production of IL-22 by mucosal ILCs.

C. rodentium induces IL-1β via Caspase-11 activation

Given that the intestinal MP1 subset from infected mice produces significant amounts of IL-1β, C. rodentium may be capable of activating an inflammasome during infection (Fig. 3). To delineate the mechanism by which monocyte-derived MP1 cells acquire the ability to produce IL-1β during C. rodentium infection, we first investigated the expression of inflammasome proteins in intestinal mononuclear phagocytes. The expression of Nlrp3, Nlrc4, Casp1, and Casp11 mRNAs were higher in MP1 than in DC1 cells, even in the steady state (supplementary Fig. 8), suggesting that expression of inflammasome proteins may contribute to the enhanced production of IL-1β by the MP1 subset. To identify which inflammasome mediates C. rodentium-induced IL-1β production in MPs, BM derived MPs (BMDMs) were stimulated with C. rodentium, and IL-1β production was measured in the culture supernatants. C. rodentium induced IL-1β and TNF-α in BMDMs (Fig. 5a). IL-1β levels induced by C. rodentium were dramatically reduced in BMDMs derived from Nlrp3−/− or Casp11−/− mice, while TNF-α production was unaffected (Fig. 5a). In contrast, Salmonella-induced IL-1β, which has been shown to be dependent on the NLRC4 inflammasome 28, was intact in Nlrp3−/− or Casp11−/− BMDMs (Fig. 5a). Given that caspase-11 acts upstream of the NLRP3 inflammasome 29, these results indicated that C. rodentium may induce IL-1β production via caspase-11-mediated non-canonical inflammasome activation. To address the role of caspase-11 in IL-1β production in vivo, Casp11−/− and Nlrp3−/− mice were infected with C. rodentium, and the production of cytokines by LP cells was evaluated ex vivo in the absence and presence of pathogen stimulation. Production of IL-1β, TNF-α and IL-6 by LP cells was enhanced by stimulation of LP cells with heat-killed C. rodentium (Fig. 5b). Importantly, the production IL-1β, but not TNF-α or IL-6, by LP cells was impaired in LP cells from infected Casp11−/− and Nlrp3−/− mice when compared to WT mice (Fig. 5b). To address the link between caspase-11 and mucosal ILC activation, we next analyzed IL-22 production by colonic ILCs during C. rodentium infection in Casp11−/− mice. Consistent with our results, IL-22 production by ILCs was significantly impaired in Casp11−/− mice (Fig. 5c). Since IL-22 induction was compromised in C. rodentium-infected Casp11−/− mice, but not in naïve Casp11−/− mice (Fig. 5d), we examined the expression of caspase-11 in colonic MPs isolated from naïve and C. rodentium-infected WT mice. Notably, the expression of caspase-11 was low or undetected in naïve mice, but was clearly detected in colonic MPs of C. rodentium-infected mice (Fig. 5e). These results indicate that C. rodentium infection induces caspase-11 expression in intestinal macrophages, and caspase-11 contributes to the production of IL-1β by MPs, which promotes mucosal defense by activating ILCs.

Figure 5. Citrobacter rodentium elicits IL-1β production by intestinal macrophages via Caspase-11 inflammasome.

Figure 5

(a) Bone-marrow derived macrophages (BMDMs) were obtained from WT, Nlrp3−/−, Casp11−/− mice and stimulated with C. rodentium (C. rod) or Salmonella (Sal) (MOI=25) for 1 hr without antibiotics and then cultured additional 17 hrs in the presence of 100 μg ml−1 gentamicin. Cytokines in the culture supernatant were analyzed by ELISA. Data are given as mean ± s.d. (n=3, representative of 3 independent experiments). (b) WT, Nlrp3−/−, Casp11−/− mice were infected with C. rodentium. On day 8 post-infection, LPMCs were isolated from the infected mice, and 2 × 106 cells ml−1 LPMCs were cultured in the presence of heat-killed C. rodentium (MOI=10) for 24 hrs. Cytokines in the culture supernatant were analyzed by ELISA. Data are given as mean ± s.d. of 3 independent experiments. *p<0.05; **p<0.01; N.S., not significant by Bonferroni test. (c) Isolated LPMCs in (b) were cultured in the presence of heat-killed C. rodentium (MOI=10) for 16 hrs. IL-22 production in CD4 ILCs (LinThy-1+CD3CD4) and CD4+ ILCs (LinThy-1+CD3CD4+) was assessed by flow cytometry. Data are representative of 4 individual mice. (d) LPMCs were isolated from uninfected and C. rodentium infected (day 8 post infection) WT and Casp11−/− mice and cultured in the presence of heat-killed C. rodentium (MOI=10) for 24 hrs. IL-22 in the culture supernatant was analyzed by ELISA. Data are given as mean ± s.e.m (n=4–6). **p<0.01; ***p<0.001; N.S., not significant by Bonferroni test. (e) CD45+MHC-II+CD11b+CD11c+CD103Gr-1 MP1 subset was sorted from naïve WT mice and C. rodentium infected (day 8) WT and Casp11−/− mice. 2 × 105 of MP1 cells were loaded with SDS-PAGE, and blotted with anti-mouse caspase-11 Ab. As positive and negative controls, BMDMs from WT and Casp11−/− mice with or without LPS priming (6 hrs) were used. The original gel images are shown in Supplementary Figure 12.

LEE virulence factors activate caspase-11 in macrophages

Lastly, we asked what factors are involved in caspase-11/NLRP3 activation by C. rodentium. BMDMs were stimulated with WT and isogenic mutant C. rodentium strains, and IL-1β production was assessed. Notably, deletion of ler, the global regulator of LEE virulence, abrogated the ability of C. rodentium to induce IL-1β release, but not TNFα (Supplementary Fig. 9a). In contrast, C. rodentium mutants deficient in the adhesion molecule Intimin (Δeae), its receptor Tir (Δtir), and type 3 secretion system (T3SS) (ΔescN, ΔescU) did not cause any defects in IL-1β production, suggesting that these Ler-regulated factors are dispensable for caspase-11 activation (Supplementary Fig. 9a). To investigate the mechanism by which Ler regulates caspase-11 activity, we determine whether C. rodentium releases a factor(s) that induces caspase-11 activity. As shown in Supplementary Fig. 9b, culture supernatant of WT C. rodentium, but not the Δler mutant strain, stimulated BMDMs to produce IL-1β in a caspase-11-dependent manner. In contrast to IL-1β, TNF-α was induced by stimulation of BMDMs with supernatant of both WT and Δler mutant (Supplementary Fig. 9b). Thus, C. rodentium Ler regulates the release of a factor (s) that mediates IL-1β production via caspase-11.

Discussion

Previous studies have revealed that intestinal mononuclear phagocytes, such as CX3CR1-expressiong cells, regulate the production of IL-22 by ILC3 cells 18, 19, 20. However, the previous works did not discriminate between resident and de novo recruited APCs. Using several approaches including CCR2-depleter (CCR2DTR) mice that do not have any defect in the development of intestinal MPs, we show that intestinal MPs arising de novo from CCR2+ monocytes play a pivotal role in induction of IL-22 by RORγt+ ILC3 cells during C. rodentium infection. Since the monocyte-derived MP1 subset in this study expresses CX3CR1 (supplementary Fig. 10), MP1 cells appear to be identical to CX3CR1+ mononuclear phagocytes reported previously 18, 19, 20. Consistently, MyD88 signaling was required for the production of IL-1β by MP1 cells (supplementary Fig. 11) and MyD88 is important for ILC activation by CX3CR1+ MPs 20. The de novo differentiated monocyte-derived CX3CR1+ MPs activate ILCs, thus playing a key role in host defense during enteric pathogen infection. In line with these studies in mice, human CD14+CX3CR1+ monocyte-derived intestinal MPs activate RORγt+ ILC3 in patients with Crohn’s disease 31, 32. Therefore, monocyte-derived MPs may contribute to host defense during infection as well as the pathogenesis of Crohn’s disease.

Monocyte-derived MPs are typically immune-regulatory under steady-state conditions 3, 33. However, intestinal MPs also initiate an inflammatory response when invasive pathogens are encountered. Hence, recruited monocytes undergo differentiation that potentiates their capacity to combat infection. Although the precise signals that direct the differentiation of monocytes into MPs within the intestine have yet to be elucidated, the mucosal microenvironment in the inflamed intestine may drive the “inflammatory” differentiation of MPs. For instance, recruited monocytes give rise to CD11c+ MPs that display a pro-inflammatory phenotype in the inflamed colon, while they primarily differentiate into a CD11c immune-regulatory subset of MPs under steady-state conditions 3, 33. Consistently, we found that intestinal infection causes recruited monocytes to differentiate preferentially into CD11c+ MPs (referred to as MP1 subset in this study) in the colonic LP. The monocyte-derived CD11c+ MP1 subset in the inflamed mucosa exhibited a more pro-inflammatory phenotype (e.g. IL-1β and IL-23 production) than the CD11c+ MP1 subset residing in the normal colon, despite identical expression of surface markers (MHCII+ CD11b+ CD11c+ F4/80+ CD103 Gr-1 CSF-1R+) associated with macrophage differentiation. This suggests that the CD11c+ MP1 population found in inflamed and non-inflamed mucosal tissue are phenotypically distinct. Likewise, monocyte-derived CD14+ MPs are identical in the intestine of Crohn’s disease patients and healthy individuals in terms of their surface markers, yet they differ in their ability to produce pro-inflammatory cytokines, with the cells isolated from the intestine of Crohn’s disease patients being more stimulatory 31. These results suggest that the local inflammatory milieu re-programs the differentiation signals for recruited monocytes, thereby inducing their preferential differentiation into pro-inflammatory CD11c+ MPs rather than regulatory CD11c MPs. Although the precise “local cues” remain unclear, microbial stimulation through pattern recognition receptors may play a role in the differentiation program of recruited monocytes into inflammatory intestinal MPs. In support of this notion, we found that the MP1 subset produces inflammatory molecules including IL-1β, TNFα and IL-6 upon stimulation with C. rodentium. Furthermore, intestinal CD11c MPs and their Ly6Chi monocyte precursors were previously shown to express TLR2 and NOD2 and produce inflammatory molecules in response to microbial ligands 33. In addition to direct microbial stimulation, “inflammatory” MP differentiation can be simultaneously influenced by local pro-inflammatory cytokines. For example, mucosal IFN-γ affects the differentiation of human intestinal MPs by promoting their pro-inflammatory activity 31.

IL-1β plays a key role in host defense by inducing several immune events involved in pathogen eradication. For instance, IL-1β acts on both endothelial and epithelial cells to promote the recruitment of neutrophils to the site of infection 34, 35. Likewise, IL-1β is critical for the differentiation of Th17 and ILC3 cells in the intestine 20, 27, 36. Our study shows that the monocyte-derived MP1 subset is a critical cellular source of IL-1β to promote ILC activation during C. rodentium infection. Although IL-1β and IL-23 synergistically enhanced the production of IL-22 by RORγt+ ILC3 isolated from the intestine, in vitro MP-ILC co-cultures and in vivo experiments supported that IL-1β, but not IL-23, is a key regulator of ILC function during C. rodentium infection. Consistent with this finding, a recent report revealed that IL-22 production by ILC3 is partly IL-23 and completely IL-1β-dependent, as CX3CR1+ mononuclear phagocytes from Il23a−/− mice displayed reduced but still significant activation of ILC3, while ILC3 from Il1r−/− mice were greatly impaired in IL-22 production 20. Moreover, IL-23 has been shown to be dispensable for IL-22 by ILCs in the intestine under steady-state conditions 37. However, previous reports suggested that IL-23 was required for IL-22 production by ILCs during infection 11, 16. Indeed, Il23a−/− mice are more susceptible to C. rodentium infection 38. Thus, further studies are needed to fully understand the role of IL-1β- and IL-23-mediated ILC3 activation in the intestine.

In addition to IL-22, IFN-γ produced by ILC3 contributes to host defense against intestinal pathogens including C. rodentium 39. Indeed, our results showed that RORγt+ ILCs produced both IL-22 and IFN-γ in vitro when stimulated with IL-1β and IL-23. Notably, RORγt+ ILCs robustly produced IFN-γ in an IL-1β-dependent manner when they were co-cultured with MP1 cells. Thus, monocyte-derived intestinal MPs can regulate both the production of IL-22 by CCR6+RORγt+T-bet ILCs and IFN-γ by CCR6RORγt+T-bet+ ILCs, and these two key cytokines may orchestrate host defense responses against infectious pathogens. Furthermore, CD14+CCR2+CX3CR1+ monocyte-derived intestinal MPs can elicit the activation of IFN-γ-producing CD3CD56+NKp46+NKp44 group 1 ILCs from Crohn’s disease patients 40. Because the barrier function of the intestinal epithelium is enhanced by IL-22, but disrupted by IFN-γ 41, 42, 43, balanced IFN-γ and IL-22 production by ILCs may affect the outcome of infectious and inflammatory disease, and further work is required to address how or whether intestinal MPs influence such an intricate balance. In addition to IL-22 and IFN-γ, monocyte depletion impaired the production of IL-17A by innate immune cells (Fig. 1i). Although IL-17A can be produced by isolated RORγt+ ILC3s (supplementary Fig. 5b), co-culture of RORγt+ ILC3s with MP1 cells did not result in the production of IL-17A by ILCs (Fig. 4a). These results indicated that in Rag1−/− mice, IL-17A is produced by a cell type other than ILC3s. This could be another subset of ILCs (e.g. ILC1) or another type of innate immune cells (e.g. neutrophils 44, 45, 46). The activation of these innate immune cells might be regulated by recruited monocytes and/or monocyte-derived MPs in the intestine.

Although IL-1β is important for the regulation of ILC3 during intestinal infection 47, the mechanism that triggers IL-1β production remains unclear. In this study, we show that intestinal MPs secrete IL-1β via the activation of the caspase-11 inflammasome in the presence of C. rodentium. Mounting evidence points to the importance of caspase-11 for the immune response against Gram-negative bacteria 29, 30. Indeed, it has been reported that the caspase-11-mediated non-canonical inflammasome activation contributes to host defense against Gram-negative enteric pathogens, such as Salmonella and C. rodentium 48, 49. Caspase-11 is expressed in both macrophages and epithelial cells in the gut 49, 50, 51, 52, and its expression is markedly induced by inflammation 51. Caspase-11 in both macrophages and epithelial cells contributes to the regulation of intestinal inflammation through the production of IL-1β and IL-18 in the gut 49, 50, 51, 52. It is known that activation of the caspase-11-mediated non-canonical inflammasome in intestinal epithelial cells maintains epithelial barrier function and promotes host defense against enteric pathogens via induction of IL-18 49, 50, 51. However, it remains largely unclear how caspase-11 functions in intestinal macrophages despite the fact that a series of in vitro experiments suggest that caspase-11 acts in macrophages to regulate the immune response to Gram-negative bacteria 29, 30. In this study, we found that caspase-11 expression in intestinal MPs is low at the steady-state, as it had been reported for NLRP3 (Fig. 5e) 34, but is increased in the de novo differentiated MPs in the inflamed intestine (Fig. 5e). As mentioned above, inflammation regulates the expression of caspase-11 in the gut 51. Another report suggested that reactive oxygen species, which are induced during inflammation, promotes the expression of caspase-11 in macrophages 53. Although the precise signals that regulate caspase-11 expression in MPs remain to be better defined, our results suggest that the inflammatory milieu up-regulates caspase-11 expression in de novo MPs which may account for their increased capacity to produce IL-1β than resident MPs. Although IL-1β production was impaired in Casp11−/− mice which was linked to reduced IL-22 production, residual IL-1β and IL-22 production in the intestine was observed even in Casp11−/− mice. Given the evidence that some commensal bacteria contribute to the production of IL-1β in intestinal MPs 36, 54, it is conceivable that commensal bacteria can contribute to IL-1β production in Casp11−/− mice. Consistently, certain commensal bacteria can activate the NLRP3 inflammasome, but not the caspase-11-dependent non-canonical pathway, to produce IL-1β 55. Thus, caspase-11 in intestinal macrophages is likely to be important, particularly in early host defense against enteric pathogens. In the later stages of infection, other inflammasomes, such as NLRP3, activated by commensal bacteria, may play a more important role in the regulation of mucosal IL-1β.

Although recent findings showed the importance of intracellular LPS for Caspase-11 activation 29, 30, the mechanism by which C. rodentium activates caspase-11 remains unclear. Our data indicate that Ler-regulated virulence factors, but not components of the type 3 secretion system and/or adhesion molecules regulated by Ler, are involved in caspase-11 activation 56. Notably, we found that Ler regulates the release of factor(s) by the pathogen that activates caspase-11 (Supplementary Fig. 9). Although LPS is a known activator of caspase-11 secreted by Gram-negative bacteria when it is delivered into the cytosol of macrophages, Ler may not regulate LPS secretion per se because TNF-α induction by C. rodentium supernatant was not impaired in the Δler mutant. Thus, one possible mechanism is that Ler regulates the secretion of factors(s) that contribute to delivery of LPS into the macrophage cytosol.

Collectively, the current study demonstrates the importance of newly recruited monocytes as well as the cross-talk between RORγt+ ILC3 and monocyte-derived intestinal MPs in host defense against intestinal infection. Since both ILC3 and intestinal MPs play vital roles in anti-inflammatory as well as pro-inflammatory responses in the intestine, understanding the complex interplay between these two types of innate immune cells may provide important insights into not only protective immunity but also the pathogenesis of inflammatory disease.

Materials & Methods

Mice

Wild-type C57BL/6, Ccr2−/−, Nlrp3−/−, Casp11−/−, Il1b−/−, RORγtGFP reporter, CD115GFP reporter mice 26 were bred and kept under specific pathogen-free (SPF) conditions in the University of Michigan Animal Facility. CCR2 reporter/depleter (CCR2CFP/DTR) mice were kindly provided by Dr. Eric Pamer (Memorial Sloan Kettering Cancer Center, New York) 22. Eight to 16 week old female and male mice were used for experiments. All animals were used All animal studies were performed under protocols approved by the University Committee on Use and Care of Animals (UCUCA) at the University of Michigan.

Reagents and Bacteria

Ultrapure Escherichia coli O111:B4 LPS and CpG were from Invivogen. Recombinant mouse IL-23 and IL-1β, neutralizatiing antibody for IL-23p19 and isotype control (rat IgG) were purchased from eBioscience. Blocking antibody for mouse IL-1β was obtained from Leinco Technologies. Kanamycin (Km)-resistant wild-type Citrobacter rodentium strain DBS120 (pCRP1::Tn5) was a gift of Dr. David Schauer (Massachusetts Institute of Technology, Massachusetts). The isogenic C. rodentium Δler, Δtir, Δeae, ΔescN, ΔescU mutants were generated from DBS120. Salmonella enterica serovar Typhimurium strain SL1344 was a gift from Dr. D. Monack (Stanford University, California). For preparation of heat-killed C. rodentium, the pathogen was cultured overnight in LB medium, inoculated into DMEM at a 1:50 dilution and cultured under standard cell culture conditions (37°C with 5% CO2) for 8 hours without shaking. Bacteria were then harvested and washed twice with ice-cold PBS, and heat inactivated at 60°C for 30 min. Complete killing of bacteria was confirmed by 72 h incubation at 37°C on bacteria growth plates.

Citrobacter rodentium Infection

C. rodentium were grown overnight in Luria-Bertani (LB) broth supplemented with Km (50 μg ml−1) with shaking at 37°C. Mice were infected by oral gavage with 0.2 ml of PBS containing approximately 1 × 109 CFU of C. rodentium. To determine bacterial numbers in the feces, fecal pellets were collected from individual mice, homogenized in cold PBS, and plated at serial dilutions onto MacConkey agar plates containing 50 μg ml−1 Km, and the number of CFU was determined after overnight incubation at 37°C. To deplete CCR2+ monocyte and monocyte-derived macrophages in vivo, 10 ng g−1 body weight of diphtheria toxin was injected i.p. on day 5, 7, 9, and 11 post-infection.

Flow Cytometric Analysis

Flow cytometry was performed using a FACSCanto II or FACSAria III and analyzed using FlowJo software (TreeStar). Dead cells were excluded with 7-AAD staining. Non-specific Ab binding was blocked with anti-CD16/32 Ab. Fluorescence-conjugated mAb against CD11b (M1/70), CD11c (N418), Gr-1 (RB6-8C5), F4/80 (BM8), Ly6C (AL-21), MHC class II I-Ab (AF6-120.1), CD103 (2E7), CD45 (30-F11), CD3 (145-2C11), CD4 (GK1.5), NKp46 (29A1.4), Thy-1.2 (53-2.1), and IL-22 (1H8PWSR) were from eBioscience. Isotype-matched antibodies (eBioscience) were used for control staining. All antibodies are used in 1:200 dilution in 1 × 106 cells/100 μl except Gr-1, Ly6C, I-Ab, and CD45 (used in 1:500 dilution).

Preparation of Lamina Propria Mononuclear Cells

Lamina propria mononuclear cells (LPMCs) were isolated from intestinal specimens using modifications of previously described techniques 57. Briefly, dissected mucosa was incubated in calcium and magnesium-free HBSS (Sigma-Aldrich) containing 2.5% heat-inactivated fetal bovine serum and 1 mM dithiothreitol (Sigma-Aldrich) to remove mucus. The mucosa was then incubated twice in HBSS containing 1 mM EDTA (Sigma-Aldrich) for 45 min at 37°C. Tissues were collected and incubated in HBSS containing 400 U ml−1 collagenase type 3 and 0.01 mg/ml DNase I (Worthington Biochemical) for 90–180 min at 37°C. The fraction was pelleted and resuspended in a 40% Percoll solution (Amersham Biosciences), then layered on 75% Percoll gradient before centrifugation at 2000 rpm for 20 min at room temperature. Viable LPMCs were recovered from the 40–75% layer interface.

Isolation of Subsets of Intestinal Cells

For isolation of intestinal Th17 cells and ILC3, LPMCs were isolated from RORγtGFP/+ reporter mice. CD11b, CD11c, CD19, B220, CD49b, CD105, MHC-II and Ter-119 expressing cells were depleted from LPMCs using a pan T cell isolation kit (Miltenyi Biotech). Enriched LP cells were then stained for CD4 and CD3. Th17 (CD3+CD4+RORγt+) and ILC3 (CD3RORγt+) were sorted using a FACSAria III cell sorter. For isolation of intestinal APC subsets, LPMCs were isolated from infected and uninfected CD115GFP reporter mice. CD115hiGr-1CD11c+CD11b+ cells (MP1) and CD115loGr-1CD11c+CD11b cells (DC1) were sorted using a FACSAria III cell sorter.

Intestinal Cell Culture

Total LPMCs or sorted intestinal cell subsets were resuspended in RPMI medium containing 10% FBS, 1% penicillin/streptomycin, 2-mercaptoethanol (50 μM), L-glutamine (2 mM), sodium pyruvate (1 mM), HEPES (1 mM), and MEM non-essential amino acids (Gibco) at 2 × 106 cells ml−1 (LPMC) or 1 × 106 cells ml−1 (sorted cells). LP cells were then incubated for 24 hrs at 37°C with or without LPS (100 ng ml−1), CpG (5 μM), or heat-killed C. rodentium (at a bacteria:host cell ratio of 10). Culture supernatants were harvested and cytokine levels were measured by ELISA. In some experiments, recombinant cytokines or neutralizating antibodies were added to cell cultures. For intracellular cytokine staining, LP cells were cultured for 16 hrs with heat-killed C. rodentium. Brefeldin A (BD bioscience) was added in the last 2 hrs of incubation and LP cells were stained, fixed and permeabilize for intracellular staining using Cytofix/Cytoperm buffer (BD Biosciences).

Quantitative Real-Time PCR

RNA was extracted using E.N.Z.A. Total RNA Kit (Omega Biotek) according to manufacturer’s instructions. Purified RNA was reverse transcribed using the High Capacity RNA-to-cDNA kit (Applied Biosystem). The cDNA was then used for quantitative PCR by the SYBR Green Gene Expression Assay (Applied Biosystem) on BioRad CFX Connect Real-Time PCR System. Primer sequences were provided in Supplementary Table 1.

BMDM in vitro Stimulation

Bone-marrow cells were cultured for 5 days with Iscove’s Modified Dulbecco’s Medium (IMDM) supplemented with 30% L929 supernatant containing macrophage-stimulating factor, glutamine, sodium pyruvate, 10% FBS and antibiotics. Differentiated BMDMs were then washed and cultured in antibiotic free IMDM supplemented with 2% FBS. BMDMs (2 × 105 cells/well/48 well plate in 200 μl) were stimulated with individual bacterial strains at a MOI=25 for 1 hr followed by 17 hrs of additional culture in the presence of gentamacin (100 μg ml−1) to prevent bacterial overgrowth. In some experiments, BMDMs were pre-treated with LPS (100 ng ml−1) for 3 hrs before bacteria stimulation. Culture supernatants were harvested and cytokines were measured by ELISA.

Monocyte Adoptive Transfer

BM cells were harvested, washed in FACS buffer and monocytes were isolated by the EasySep® Mouse Monocyte Enrichment Kit (STEMCELL Technologies Inc). Monocytes were counted and transferred by i.v. injection of 2 × 106 in the tail vein of Ccr2−/− mice 4 days after oral infection with C. rodentium.

Mixed Bone Marrow Chimera Mice

To generate mixed BM chimera mice, 10–12 week-old WT recipient mice were lethally irradiated using X-rays (Phillips RT250, Kimtron Medical) with two doses of 540 rads (total 1,080) delivered 3 hours apart on the same day, then 5 × 106 of BM cells from CCR2WT or CCR2DTR mice mixed with 5 × 106 of BM cells from Il1b−/− mice and transplanted into recipient mice via tail vein injection. Recipient mice were rested for at least 8 weeks before use.

Immunoblotting of caspase-11

The CD45+MHC-II+CD11b+CD11c+CD103Gr-1 MP1 cell subset was purified from LPMCs isolated from naïve or C. rodentiun-infected (day 8) mice using a FACSAria cell sorter. FACS purified cells (2 × 105 cells) were lysed in a buffer containing 1% NP-40 supplemented with the complete protease inhibitor cocktail (Roche, Mannheim, Germany) and 2 mM dithiothreitol. Lysates were resolved by SDS-PAGE and transferred to PVDF membranes by electro-blotting. Rat anti mouse-caspase-11 antibody (17D9, Sigma) was used to detect caspase-11 in MPs (1:1000 dilution).

Statistical Analyses

Statistical analyses were performed using GraphPad Prism software version 5.0 (GraphPad Software Inc.). Differences between two groups were evaluated using Student’s t test (parametric) or Mann-Whitney U test (non-parametric). For the comparison of more than 3 groups, statistical analysis was performed using one-way ANOVA (parametric) or Kruscal-Wallis test (non-parametric), and then the Dunnett’s or Bonferroni test for parametric samples, or Dunn’s test for non-parametric samples as a post-hoc test. Survival between groups of mice was compared using Log-rank (Mantel-Cox) test. Differences at P<0.05 were considered significant.

Supplementary Material

1

Acknowledgments

The authors thank Drs. Mo El-Zaatari, Helmut Grasberger, Andrew Shreiner, and John Kao for helpful discussion, Joel Whitfield of the University of Michigan Immunology Core for performing ELISAs, Dahai Yang and Yuan He for caspase-11 immunoblotting, and Melody Zeng and Judith Connett for critical reading of the manuscript. This work was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology 2013R1A6A3A03024348 (to S.-U. S), JSPS Postdoctoral Fellow for Research Abroad (to S. K. and H. N.-K.), Career Development Awards from the Crohn’s and Colitis Foundation of America (to Y.-G. K and N. K.), Michigan Gastrointestinal Peptide Research Center NIDDK DK034933 (to N. K.), NIH grants DK091191 and DK095782 (to G. N.).

Footnotes

Author Contributions

S.-U.S. and N.K. conceived and designed experiments. S.-U.S., P.K., S.K., H.N.-K., and N.K. conduced experiments. Y.-G. K. and G.N. helped with critical advice and discussion. S.-U.S. and N.K analyzed all the data and wrote the manuscript with contributions from all authors.

Disclosure

The authors declared no conflict of interest.

References

  • 1.Cerovic V, Bain CC, Mowat AM, Milling SW. Intestinal macrophages and dendritic cells: what’s the difference? Trends Immunol. 2014;35(6):270–277. doi: 10.1016/j.it.2014.04.003. [DOI] [PubMed] [Google Scholar]
  • 2.Denning TL, Norris BA, Medina-Contreras O, Manicassamy S, Geem D, Madan R, et al. Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization. J Immunol. 2011;187(2):733–747. doi: 10.4049/jimmunol.1002701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Rivollier A, He J, Kole A, Valatas V, Kelsall BL. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J Exp Med. 2012;209(1):139–155. doi: 10.1084/jem.20101387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Denning TL, Wang YC, Patel SR, Williams IR, Pulendran B. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol. 2007;8(10):1086–1094. doi: 10.1038/ni1511. [DOI] [PubMed] [Google Scholar]
  • 5.Ginhoux F, Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat Rev Immunol. 2014;14(6):392–404. doi: 10.1038/nri3671. [DOI] [PubMed] [Google Scholar]
  • 6.Bain CC, Scott CL, Uronen-Hansson H, Gudjonsson S, Jansson O, Grip O, et al. Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol. 2013;6(3):498–510. doi: 10.1038/mi.2012.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Dunay IR, Damatta RA, Fux B, Presti R, Greco S, Colonna M, et al. Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity. 2008;29(2):306–317. doi: 10.1016/j.immuni.2008.05.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Dunay IR, Fuchs A, Sibley LD. Inflammatory monocytes but not neutrophils are necessary to control infection with Toxoplasma gondii in mice. Infect Immun. 2010;78(4):1564–1570. doi: 10.1128/IAI.00472-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kim YG, Kamada N, Shaw MH, Warner N, Chen GY, Franchi L, et al. The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes. Immunity. 2011;34(5):769–780. doi: 10.1016/j.immuni.2011.04.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Simmons CP, Clare S, Ghaem-Maghami M, Uren TK, Rankin J, Huett A, et al. Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium. Infect Immun. 2003;71(9):5077–5086. doi: 10.1128/IAI.71.9.5077-5086.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Sonnenberg GF, Monticelli LA, Elloso MM, Fouser LA, Artis D. CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity. 2011;34(1):122–134. doi: 10.1016/j.immuni.2010.12.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Walker JA, Barlow JL, McKenzie AN. Innate lymphoid cells - how did we miss them? Nat Rev Immunol. 2013;13(2):75–87. doi: 10.1038/nri3349. [DOI] [PubMed] [Google Scholar]
  • 13.Sonnenberg GF, Artis D. Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. Immunity. 2012;37(4):601–610. doi: 10.1016/j.immuni.2012.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JK, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature. 2009;457(7230):722–725. doi: 10.1038/nature07537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Spits H, Di Santo JP. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol. 2011;12(1):21–27. doi: 10.1038/ni.1962. [DOI] [PubMed] [Google Scholar]
  • 16.Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med. 2008;14(3):282–289. doi: 10.1038/nm1720. [DOI] [PubMed] [Google Scholar]
  • 17.Kinnebrew MA, Buffie CG, Diehl GE, Zenewicz LA, Leiner I, Hohl TM, et al. Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. Immunity. 2012;36(2):276–287. doi: 10.1016/j.immuni.2011.12.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Manta C, Heupel E, Radulovic K, Rossini V, Garbi N, Riedel CU, et al. CX(3)CR1(+) macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium. Mucosal Immunol. 2013;6(1):177–188. doi: 10.1038/mi.2012.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Tumanov AV, Koroleva EP, Guo X, Wang Y, Kruglov A, Nedospasov S, et al. Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge. Cell Host Microbe. 2011;10(1):44–53. doi: 10.1016/j.chom.2011.06.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Longman RS, Diehl GE, Victorio DA, Huh JR, Galan C, Miraldi ER, et al. CX3CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med. 2014 doi: 10.1084/jem.20140678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Serbina NV, Pamer EG. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol. 2006;7(3):311–317. doi: 10.1038/ni1309. [DOI] [PubMed] [Google Scholar]
  • 22.Hohl TM, Rivera A, Lipuma L, Gallegos A, Shi C, Mack M, et al. Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection. Cell Host Microbe. 2009;6(5):470–481. doi: 10.1016/j.chom.2009.10.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5(12):953–964. doi: 10.1038/nri1733. [DOI] [PubMed] [Google Scholar]
  • 24.Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol. 2011;11(11):762–774. doi: 10.1038/nri3070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19(1):71–82. doi: 10.1016/s1074-7613(03)00174-2. [DOI] [PubMed] [Google Scholar]
  • 26.Burnett SH, Beus BJ, Avdiushko R, Qualls J, Kaplan AM, Cohen DA. Development of peritoneal adhesions in macrophage depleted mice. J Surg Res. 2006;131(2):296–301. doi: 10.1016/j.jss.2005.08.026. [DOI] [PubMed] [Google Scholar]
  • 27.Reynders A, Yessaad N, Vu Manh TP, Dalod M, Fenis A, Aubry C, et al. Identity, regulation and in vivo function of gut NKp46+RORgammat+ and NKp46+RORgammat- lymphoid cells. EMBO J. 2011;30(14):2934–2947. doi: 10.1038/emboj.2011.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Franchi L, Amer A, Body-Malapel M, Kanneganti TD, Ozoren N, Jagirdar R, et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol. 2006;7(6):576–582. doi: 10.1038/ni1346. [DOI] [PubMed] [Google Scholar]
  • 29.Rathinam VA, Vanaja SK, Waggoner L, Sokolovska A, Becker C, Stuart LM, et al. TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell. 2012;150(3):606–619. doi: 10.1016/j.cell.2012.07.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S, Dong J, et al. Non-canonical inflammasome activation targets caspase-11. Nature. 2011;479(7371):117–121. doi: 10.1038/nature10558. [DOI] [PubMed] [Google Scholar]
  • 31.Kamada N, Hisamatsu T, Okamoto S, Chinen H, Kobayashi T, Sato T, et al. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J Clin Invest. 2008;118(6):2269–2280. doi: 10.1172/JCI34610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Mizuno S, Mikami Y, Kamada N, Handa T, Hayashi A, Sato T, et al. Cross-talk Between RORgammat+ Innate Lymphoid Cells and Intestinal Macrophages Induces Mucosal IL-22 Production in Crohn’s Disease. Inflamm Bowel Dis. 2014 doi: 10.1097/MIB.0000000000000105. [DOI] [PubMed] [Google Scholar]
  • 33.Zigmond E, Varol C, Farache J, Elmaliah E, Satpathy AT, Friedlander G, et al. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity. 2012;37(6):1076–1090. doi: 10.1016/j.immuni.2012.08.026. [DOI] [PubMed] [Google Scholar]
  • 34.Franchi L, Kamada N, Nakamura Y, Burberry A, Kuffa P, Suzuki S, et al. NLRC4-driven production of IL-1beta discriminates between pathogenic and commensal bacteria and promotes host intestinal defense. Nat Immunol. 2012;13(5):449–456. doi: 10.1038/ni.2263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Hasegawa M, Kamada N, Jiao Y, Liu MZ, Nunez G, Inohara N. Protective Role of Commensals against Clostridium difficile Infection via an IL-1beta-Mediated Positive-Feedback Loop. J Immunol. 2012 doi: 10.4049/jimmunol.1200821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Shaw MH, Kamada N, Kim YG, Nunez G. Microbiota-induced IL-1beta, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine. J Exp Med. 2012;209(2):251–258. doi: 10.1084/jem.20111703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Sawa S, Lochner M, Satoh-Takayama N, Dulauroy S, Berard M, Kleinschek M, et al. RORgammat+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat Immunol. 2011;12(4):320–326. doi: 10.1038/ni.2002. [DOI] [PubMed] [Google Scholar]
  • 38.Basu R, O’Quinn DB, Silberger DJ, Schoeb TR, Fouser L, Ouyang W, et al. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity. 2012;37(6):1061–1075. doi: 10.1016/j.immuni.2012.08.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Klose CS, Kiss EA, Schwierzeck V, Ebert K, Hoyler T, d’Hargues Y, et al. A T-bet gradient controls the fate and function of CCR6-RORgammat+ innate lymphoid cells. Nature. 2013;494(7436):261–265. doi: 10.1038/nature11813. [DOI] [PubMed] [Google Scholar]
  • 40.Takayama T, Kamada N, Chinen H, Okamoto S, Kitazume MT, Chang J, et al. Imbalance of NKp44(+)NKp46(−) and NKp44(−)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn’s disease. Gastroenterology. 2010;139(3):882–892. 892 e881–883. doi: 10.1053/j.gastro.2010.05.040. [DOI] [PubMed] [Google Scholar]
  • 41.Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M, et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med. 2009;206(7):1465–1472. doi: 10.1084/jem.20082683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Ferrier L, Mazelin L, Cenac N, Desreumaux P, Janin A, Emilie D, et al. Stress-induced disruption of colonic epithelial barrier: role of interferon-gamma and myosin light chain kinase in mice. Gastroenterology. 2003;125(3):795–804. doi: 10.1016/s0016-5085(03)01057-6. [DOI] [PubMed] [Google Scholar]
  • 43.Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, Turner JR. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol. 2005;166(2):409–419. doi: 10.1016/s0002-9440(10)62264-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Werner JL, Gessner MA, Lilly LM, Nelson MP, Metz AE, Horn D, et al. Neutrophils produce interleukin 17A (IL-17A) in a dectin-1- and IL-23-dependent manner during invasive fungal infection. Infect Immun. 2011;79(10):3966–3977. doi: 10.1128/IAI.05493-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Li L, Huang L, Vergis AL, Ye H, Bajwa A, Narayan V, et al. IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest. 2010;120(1):331–342. doi: 10.1172/JCI38702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Taylor PR, Roy S, Leal SM, Jr, Sun Y, Howell SJ, Cobb BA, et al. Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORgammat and dectin-2. Nat Immunol. 2014;15(2):143–151. doi: 10.1038/ni.2797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Coccia M, Harrison OJ, Schiering C, Asquith MJ, Becher B, Powrie F, et al. IL-1beta mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells. J Exp Med. 2012;209(9):1595–1609. doi: 10.1084/jem.20111453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Gurung P, Malireddi RK, Anand PK, Demon D, Vande Walle L, Liu Z, et al. Toll or interleukin-1 receptor (TIR) domain-containing adaptor inducing interferon-beta (TRIF)-mediated caspase-11 protease production integrates Toll-like receptor 4 (TLR4) protein- and Nlrp3 inflammasome-mediated host defense against enteropathogens. J Biol Chem. 2012;287(41):34474–34483. doi: 10.1074/jbc.M112.401406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Knodler LA, Crowley SM, Sham HP, Yang H, Wrande M, Ma C, et al. Noncanonical inflammasome activation of caspase-4/caspase-11 mediates epithelial defenses against enteric bacterial pathogens. Cell Host Microbe. 2014;16(2):249–256. doi: 10.1016/j.chom.2014.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Demon D, Kuchmiy A, Fossoul A, Zhu Q, Kanneganti TD, Lamkanfi M. Caspase-11 is expressed in the colonic mucosa and protects against dextran sodium sulfate-induced colitis. Mucosal Immunol. 2014;7(6):1480–1491. doi: 10.1038/mi.2014.36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Oficjalska K, Raverdeau M, Aviello G, Wade SC, Hickey A, Sheehan KM, et al. Protective role for caspase-11 during acute experimental murine colitis. J Immunol. 2015;194(3):1252–1260. doi: 10.4049/jimmunol.1400501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Williams TM, Leeth RA, Rothschild DE, McDaniel DK, Coutermarsh-Ott SL, Simmons AE, et al. Caspase-11 attenuates gastrointestinal inflammation and experimental colitis pathogenesis. Am J Physiol Gastrointest Liver Physiol. 2015;308(2):G139–150. doi: 10.1152/ajpgi.00234.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Lupfer CR, Anand PK, Liu Z, Stokes KL, Vogel P, Lamkanfi M, et al. Reactive oxygen species regulate caspase-11 expression and activation of the non-canonical NLRP3 inflammasome during enteric pathogen infection. PLoS Pathog. 2014;10(9):e1004410. doi: 10.1371/journal.ppat.1004410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Mortha A, Chudnovskiy A, Hashimoto D, Bogunovic M, Spencer SP, Belkaid Y, et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science. 2014;343(6178):1249288. doi: 10.1126/science.1249288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Seo SU, Kamada N, Munoz-Planillo R, Kim YG, Kim D, Koizumi Y, et al. Distinct Commensals Induce Interleukin-1beta via NLRP3 Inflammasome in Inflammatory Monocytes to Promote Intestinal Inflammation in Response to Injury. Immunity. 2015;42(4):744–755. doi: 10.1016/j.immuni.2015.03.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Deng W, Puente JL, Gruenheid S, Li Y, Vallance BA, Vazquez A, et al. Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc Natl Acad Sci U S A. 2004;101(10):3597–3602. doi: 10.1073/pnas.0400326101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Kamada N, Hisamatsu T, Okamoto S, Sato T, Matsuoka K, Arai K, et al. Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J Immunol. 2005;175(10):6900–6908. doi: 10.4049/jimmunol.175.10.6900. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES